A Synthetic Binder of Breast Cancer Stem Cells

被引:2
作者
Chen, Luxi [1 ]
Long, Chao [1 ]
Tran, Kha Andy Minh [1 ]
Lee, Jiyong [1 ]
机构
[1] Univ Texas Dallas, Dept Chem & Biochem, 800 W Campbell Rd, Richardson, TX 75080 USA
关键词
biological chemistry; cancer; high-throughput screening; stem cells; tumors; IDENTIFICATION; PHENOTYPE; SELECTION; FEATURES; SUBTYPES; LIGANDS;
D O I
10.1002/chem.201705663
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cancer stem cells (CSCs) are associated with drug resistance, metastasis and recurrence of cancer. A synthetic binder of CSCs can provide a valuable tool to study the biology of CSCs and a lead to develop imaging, diagnostic and therapeutic agents targeting CSCs. Herein, a synthetic ligand(1) that specifically binds to CSCs over non-CSCs of breast cancer cells was identified for the first time via a cell-binding screening of a chemical library. The ligand 1 showed specific binding to CD24(-)/CD44(+)/ALDH(+) CSC population of MCF-7 and MDA-MB-231. We have demonstrated that 1-immobilized beads can be used as matrices for affinity isolation of 1-binding CSC population from breast cancer cells. The 1-binding population showed significantly increased expressions of stemness-associated transcription factors. Importantly, the 1-binding population demonstrated accelerated tumor growth in vivo, and the resulting tumor displayed an increased migratory activity and high expressions of CSC markers.
引用
收藏
页码:3694 / 3698
页数:5
相关论文
共 28 条
  • [1] Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways
    Abetov, Danysh
    Mustapova, Zhanar
    Saliev, Timur
    Bulanin, Denis
    Batyrbekov, Kanat
    Gilman, Charles P.
    [J]. STEM CELL REVIEWS AND REPORTS, 2015, 11 (06) : 909 - 918
  • [2] Prospective identification of tumorigenic breast cancer cells
    Al-Hajj, M
    Wicha, MS
    Benito-Hernandez, A
    Morrison, SJ
    Clarke, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3983 - 3988
  • [3] Isolation of protein ligands from large peptoid libraries
    Alluri, PG
    Reddy, MM
    Bachhawat-Sikder, K
    Olivos, HJ
    Kodadek, T
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (46) : 13995 - 14004
  • [4] Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
    Bauer, Katrina R.
    Brown, Monica
    Cress, Rosemary D.
    Parise, Carol A.
    Caggiano, Vincent
    [J]. CANCER, 2007, 109 (09) : 1721 - 1728
  • [5] Residual risk of breast cancer recurrence 5 years after adjuvant therapy
    Brewster, Abenaa M.
    Hortobagyi, Gabriel N.
    Broglio, Kristine R.
    Kau, Shu-Wan
    Santa-Maria, Cesar A.
    Arun, Banu
    Buzdar, Arnan U.
    Booser, Daniel J.
    Valero, Vincente
    Bondy, Melissa
    Esteva, Francisco J.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16): : 1179 - 1183
  • [6] Periodate-triggered cross-linking of DOPA-containing peptide-protein complexes
    Burdine, L
    Gillette, TG
    Lin, HJ
    Kodadek, T
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (37) : 11442 - 11443
  • [7] Choi J, 2012, HISTOL HISTOPATHOL, V27, P1481, DOI 10.14670/HH-27.1481
  • [8] The cancer stem cell: premises, promises and challenges
    Clevers, Hans
    [J]. NATURE MEDICINE, 2011, 17 (03) : 313 - 319
  • [9] Triple-negative breast cancer: Clinical features and patterns of recurrence
    Dent, Rebecca
    Trudeau, Maureen
    Pritchard, Kathleen I.
    Hanna, Wedad M.
    Kahn, Harriet K.
    Sawka, Carol A.
    Lickley, Lavina A.
    Rawlinson, Ellen
    Sun, Ping
    Narod, Steven A.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4429 - 4434
  • [10] Stem cell concepts renew cancer research
    Dick, John E.
    [J]. BLOOD, 2008, 112 (13) : 4793 - 4807